Articles with "recombinant activated" as a keyword



Photo from wikipedia

Topical application of recombinant activated factor VII during cesarean delivery for placenta previa

Sign Up to like & get
recommendations!
Published in 2017 at "American Journal of Obstetrics and Gynecology"

DOI: 10.1016/j.ajog.2017.02.024

Abstract: BACKGROUND: During cesarean delivery in patients with placenta previa, hemorrhaging after removal of the placenta is often challenging. In this condition, the extraordinarily high concentration of tissue factor at the placenta site may constitute a… read more here.

Keywords: factor vii; activated factor; placenta; factor ... See more keywords
Photo from wikipedia

Off-label Use of Recombinant Activated Factor VII for Cardiac Surgical Bleeding.

Sign Up to like & get
recommendations!
Published in 2023 at "Anesthesiology"

DOI: 10.1097/aln.0000000000004569

Abstract: Recombinant activated factor VII has been widely used in an off-label manner for cardiac surgical bleeding. Recent reports have administered recombinant activated factor VII earlier in the course of bleeding and at lower doses than… read more here.

Keywords: cardiac surgical; recombinant activated; activated factor; factor vii ... See more keywords
Photo from wikipedia

Recombinant activated factor seven in pediatric cardiac surgery-does thrombotic risk outweigh hemostatic benefit?

Sign Up to like & get
recommendations!
Published in 2019 at "Translational pediatrics"

DOI: 10.21037/tp.2019.10.04

Abstract: Therapies employed to attenuate perioperative bleeding following cardiopulmonary bypass (CPB) in children include antifibrinolytic therapy, allogenic blood product transfusion, and recombinant factor concentrates. Recombinant activated factor seven (rFVIIa) (Novoseven RT, Novo Nordisk A/S, Denmark) is… read more here.

Keywords: factor seven; activated factor; seven pediatric; pediatric cardiac ... See more keywords
Photo from wikipedia

Recombinant Activated Factor VII in Aortic Surgery for Patients Under Hypothermic Circulatory Arrest

Sign Up to like & get
recommendations!
Published in 2022 at "Therapeutics and Clinical Risk Management"

DOI: 10.2147/tcrm.s352609

Abstract: Purpose We aimed to identify the risk factors of critical bleeding and investigate the safety of recombinant activated factor VII (rFVIIa) in aortic surgery under hypothermic circulatory arrest (HCA). Patients and Methods The present single-center… read more here.

Keywords: activated factor; factor vii; surgery; recombinant activated ... See more keywords